Meeting
2023 ASCO Annual Meeting
A multi-center natural history study of precision-based genomics in prostate cancer (PC).
Authors
Himisha Beltran
Dana-Farber Cancer Institute, Boston, MA
Himisha Beltran , Joaquin Mateo , Wassim Abida , Rana R. McKay , Robert Bruce Montgomery , Rahul Raj Aggarwal , Katherine Lee-Wisdom , William Douglas Figg , William L. Dahut , Fatima Karzai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Other Prostate, Testicular, or Penile Cancer
Clinical Trial Registration Number
NCT04706663
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS5121)
DOI
10.1200/JCO.2023.41.16_suppl.TPS5121
Abstract #
TPS5121
Poster Bd #
203b
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
First Author: Elias Chandran
Poster
2023 ASCO Genitourinary Cancers Symposium
Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).
First Author: Anna Couvillon
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.
First Author: Jose Luis Rodriguez Olivares
Poster
2023 ASCO Annual Meeting
Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world.
First Author: Seng Wee Cheo